Edition:
United Kingdom

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

8.03USD
17 Nov 2017
Change (% chg)

$0.03 (+0.38%)
Prev Close
$8.00
Open
$7.95
Day's High
$8.18
Day's Low
$7.95
Volume
4,098
Avg. Vol
9,657
52-wk High
$13.18
52-wk Low
$7.71

Latest Key Developments (Source: Significant Developments)

Obalon Therapeutics Q3 loss per share $0.55
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Obalon Therapeutics Inc :Obalon announces third quarter 2017 financial results.Q3 revenue $2.8 million versus I/B/E/S view $2.9 million.Q3 loss per share $0.55.Q3 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S.  Full Article

Obalon Therapeutics & Sono Bello announce agreement to offer novel weight loss treatment
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Obalon Therapeutics Inc :Obalon Therapeutics Inc and Sono Bello announce agreement to offer novel weight loss treatment in Sono Bello centers.Obalon Therapeutics Inc - ‍co, Sono Bello announced that they had reached an agreement to begin offering Obalon balloon system​.Obalon Therapeutics Inc - ‍Obalon balloon system will be exclusive non-invasive weight loss technology offered in Sono Bello centers​.  Full Article

Obalon Therapeutics files for mixed shelf of up to $100 mln
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Obalon Therapeutics Inc ::Files for mixed shelf of up to $100 million - SEC filing‍​.Says in addition, selling stockholder may offer and sell up to 150,000 shares of co's common stock.  Full Article

Obalon Therapeutics says announced pricing of IPO of 5 mln shares at $15/shr
Thursday, 6 Oct 2016 

Obalon Therapeutics Inc : Obalon therapeutics announces pricing of initial public offering .Says announced pricing of its ipo of 5 million shares of its common stock at a price to public of $15.00 per share.  Full Article

Obalon Therapeutics says announced pricing of IPO of 5 mln shares at $15/shr
Thursday, 6 Oct 2016 

Obalon Therapeutics Inc : Obalon therapeutics announces pricing of initial public offering .Says announced pricing of its ipo of 5 million shares of its common stock at a price to public of $15.00 per share.  Full Article

BRIEF-Obalon Therapeutics Q3 loss per share $0.55

* Q3 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: